Bavarian Nordic A/S (BVNRY)
OTCMKTS
· Delayed Price · Currency is USD
8.83
0.00 (0.05%)
Jul 2, 2025, 3:30 PM EDT
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.35B DKK in the quarter ending March 31, 2025, with 61.95% growth. This brings the company's revenue in the last twelve months to 6.23B, down -6.18% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72B, down -19.06%.
Revenue (ttm)
6.23B DKK
Revenue Growth
-6.18%
P/S Ratio
2.30
Revenue / Employee
3.88M DKK
Employees
1,605
Market Cap
2.08B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Bavarian Nordic News
- 6 days ago - Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women - GlobeNewsWire
- 20 days ago - Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children - GlobeNewsWire
- 7 weeks ago - Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 7 weeks ago - Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Bavarian Nordic A/S reports interim Q1 results - Seeking Alpha
- 7 weeks ago - Bavarian Nordic Announces Interim Results for the First Three Months of 2025 - GlobeNewsWire
- 2 months ago - Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines - GlobeNewsWire